A sequence-specific exopeptidase activity test (SSEAT) for "functional" biomarker discovery

Josep Villanueva1, Arpi Nazarian, Kevin Lawlor

  • 1Protein Center, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.

Summary

This study introduces a novel assay to measure exoprotease activity in biological samples. The assay accurately distinguishes metastatic thyroid cancer patients from healthy controls, demonstrating high sensitivity and specificity.

Related Concept Videos